Overview
- The EPA’s draft Sixth Contaminant Candidate List names microplastics and pharmaceuticals for drinking-water review and opens a public comment window before a final list later this year.
- HHS announced STOMP, an about $144 million ARPA-H effort to build tools to detect microplastics in people, map how they move through the body, and explore ways to remove them.
- Officials emphasized measurement gaps and the need for consistent lab methods, while researchers pointed to early studies that link microplastics to inflammation and potential heart, brain, and fertility risks.
- Environmental groups called the listing a first step and urged exposure limits and a pause on permits for new plastic plants, while the American Chemistry Council backed monitoring if testing is standardized nationwide.
- The CCL guides what EPA studies and monitors next, yet prior cycles rarely yielded enforceable drinking-water standards, which means any future limits will depend on new evidence and could take years.